Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Humphreys

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
BJU International|March 18, 2008
Progression after radical prostatectomy for men in their thirties compared to older menStacy Loeb, David J Hernandez, Leslie A Mangold, et al.
Parasites & Vectors|January 7, 2017
Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidateWenqi Zheng, Fei Liu, Yiwen He, et al.
The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
BJU International|July 23, 2011
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upEmmanuel S Antonarakis, Zhaoyong Feng, Bruce J Trock, et al.
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Developmental Biology|June 26, 2013
Mummy, A UDP-N-acetylglucosamine pyrophosphorylase, modulates DPP signaling in the embryonic epidermis of DrosophilaGregory B Humphreys, Molly C Jud, Kathryn M Monroe, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
BJU International|March 18, 2008
Progression after radical prostatectomy for men in their thirties compared to older menStacy Loeb, David J Hernandez, Leslie A Mangold, et al.
Parasites & Vectors|January 7, 2017
Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidateWenqi Zheng, Fei Liu, Yiwen He, et al.
The Journal of Urology|July 4, 2006
Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/mlDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
BJU International|July 23, 2011
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upEmmanuel S Antonarakis, Zhaoyong Feng, Bruce J Trock, et al.
The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.
Developmental Biology|June 26, 2013
Mummy, A UDP-N-acetylglucosamine pyrophosphorylase, modulates DPP signaling in the embryonic epidermis of DrosophilaGregory B Humphreys, Molly C Jud, Kathryn M Monroe, et al.
Pageof 6